NEW YORK (360Dx) – After a fruitful June, the 360Dx Index was nearly flat month over month in July, as it trailed the broader market.

Overall, the index rose less than 1 percent last month. Shares for 14 of the 26 companies comprising the index took a hit in July while 10 firms' stock prices rose. One company, GenMark Diagnostics, saw no change in its share price.

The index trailed the Dow Jones Industrial Average, the Nasdaq Composite, and the Nasdaq Biotech indices, which each grew approximately 3 percent month over month.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.